STAAR Surgical to Present at Three Investor Conferences

Thursday, July 29, 2010 Press Release J E 4

MONROVIA, Calif., July 29 STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in the three following upcoming investor conferences during the first two weeks of August:

Attendance at these conferences is by invitation only. Barry G. Caldwell, President and CEO, will review the company's business strategy and recent corporate developments.

About STAAR Surgical

STAAR, which has been solely dedicated to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." A lens used in refractive surgery as an alternative to LASIK is called an Implantable CollamerŪ Lens or "ICL." Over 180,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: STAAR has approximately 300 full time employees and markets lenses in approximately 50 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at: or call 626-303-7902.

The BMO Capital Markets 10th Annual Focus on Healthcare Conference Thursday, August 5, 2010 New York, NY 11:15 a.m. ET Webcast available at 2010healthcare/webcast Collins Stewart 2010 Health Care Event Wednesday, August 11, 2010 New York, NY 30th Annual Canaccord Global Growth Conference Thursday, August 12, 2010 Boston, MA 2:00 p.m. ET Webcast available on STAAR's Investor Relations page at:

SOURCE STAAR Surgical Company


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Cardio3 BioSciences Hosts Visiting Scientist
Questcor to Participate in Upcoming Conferences